Interestingly, we did not observe an effect of BML‐111 treatment on anti‐inflammatory cytokines IL‐10 and IL‐4 at 1 week post‐stroke, despite increased CD163+ microglia/macrophages. The gene discussed is CD163; the disease is stroke disorder.